Provenienza dei contatti di primo grado di Mark Troutfetter
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Pristine, Inc.
 Pristine, Inc. Packaged SoftwareTechnology Services Pristine, Inc. provides enterprise software solutions for smart glasses. Its product EyeSight, offers industrial and healthcare solutions. The firm offers video communication platform primarily for health care providers, delivering information and allowing communication on the device's optics. The company was founded by Kyle Samani and Patrick Kolencherry in 2013 and is headquartered in Austin, TX.
4
| Subsidiary | Packaged Software | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Troutfetter tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Southern Illinois University | College/University | Doctorate Degree | |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Medical Specialties | Chief Executive Officer | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
WaferGen, Inc.
 WaferGen, Inc. BiotechnologyHealth Technology WaferGen, Inc. develops novel products for cell biology and genetic analysis. The firm focuses on the development systems for gene expression, genotyping and stem cell research for the life science and pharmaceutical industries. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda and is headquartered in Fremont, CA. | Biotechnology | Chief Executive Officer | |
Immunexpress, Inc.
 Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Settori
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Posizioni
| Chief Executive Officer | 5 |
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| President | 3 |
| Founder | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Rolland D. Carlson | 8 |
| Peter Evans | 1 |
| Arik Yaacob | 1 |
| Chris Delvizis | 1 |
- Borsa valori
- Insiders
- Mark Troutfetter
- Connessioni Società
